Pharmacological treatment of postmenopausal osteoporosis

Daniel G. Fernández Ávila; Claudia Mora; Elsa Reyes Sanmiguel; John Darío Londoño; Pedro Santos Moreno; Rafael Valle-Oñate

doi:10.1016/S0121-8123(10)70084-0

Pharmacological treatment of postmenopausal osteoporosis

Título traducido de la contribución: Tratamiento farmacológico de la osteoporosis postmenopáusica

Daniel G. Fernández Ávila, Claudia Mora, Elsa Reyes Sanmiguel, John Darío Londoño, Pedro Santos Moreno, Rafael Valle-Oñate

Producción: Contribución a una revista › Artículo de revisión › revisión exhaustiva

2 Citas (Scopus)

Resumen

Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.

Título traducido de la contribución	Tratamiento farmacológico de la osteoporosis postmenopáusica
Idioma original	Inglés
Páginas (desde-hasta)	96-110
Número de páginas	15
Publicación	Revista Colombiana de Reumatologia
Volumen	17
N.º	2
DOI	https://doi.org/10.1016/S0121-8123(10)70084-0
Estado	Publicada - 01 jun. 2010
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/S0121-8123(10)70084-0

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{5b1e0ac9fd56497eaa8dd84a9d121891,

title = "Pharmacological treatment of postmenopausal osteoporosis",

abstract = "Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.",

keywords = "bone mineral density, fracture, menopause, osteoporosis",

author = "{Fern{\'a}ndez {\'A}vila}, {Daniel G.} and Claudia Mora and Sanmiguel, {Elsa Reyes} and Londo{\~n}o, {John Dar{\'i}o} and Moreno, {Pedro Santos} and Rafael Valle-O{\~n}ate",

note = "Publisher Copyright: {\textcopyright} 2010 Asociaci{\'o}n Colombiana de Reumatolog{\'i}a",

year = "2010",

month = jun,

day = "1",

doi = "10.1016/S0121-8123(10)70084-0",

language = "English",

volume = "17",

pages = "96--110",

journal = "Revista Colombiana de Reumatologia",

issn = "0121-8123",

publisher = "Asociacion Colombiana de Reumatologia",

number = "2",

}

TY - JOUR

T1 - Pharmacological treatment of postmenopausal osteoporosis

AU - Fernández Ávila, Daniel G.

AU - Mora, Claudia

AU - Sanmiguel, Elsa Reyes

AU - Londoño, John Darío

AU - Moreno, Pedro Santos

AU - Valle-Oñate, Rafael

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.

AB - Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.

KW - bone mineral density

KW - fracture

KW - menopause

KW - osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=85025696137&partnerID=8YFLogxK

U2 - 10.1016/S0121-8123(10)70084-0

DO - 10.1016/S0121-8123(10)70084-0

M3 - Review article

AN - SCOPUS:85025696137

SN - 0121-8123

VL - 17

SP - 96

EP - 110

JO - Revista Colombiana de Reumatologia

JF - Revista Colombiana de Reumatologia

IS - 2

ER -

Pharmacological treatment of postmenopausal osteoporosis

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto